PEOPLE - New president for Gish Biomedical:
This article was originally published in Clinica
CardioTech International (Woburn, Massachusetts) has promoted Douglas Whittaker to the position of president of its medical device manufacturing subsidiary Gish Biomedical. Mr Whittaker, who most recently served as director of worldwide sales, replaces Kelly Scott, who also served as CEO.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.